Profusa, Inc.

Profusa, Inc. (ticker: PFSA) is a medical technology company operating in the implantable biosensor space, focused on continuous, real-time monitoring of human body chemistry through tissue-integrated sensor platforms. The company filed a Form 10-Q with the SEC on November 20, 2023, under accession number 0001213900-23-088706, reflecting its standing as a reporting public company in the healthcare and medical device sector. Profusa's platform targets clinical and consumer health monitoring applications. Investors and analysts tracking PFSA's SPAC lineage, sponsor details, and post-merger financials can sign up at SpacDesk for full historical and real-time data coverage.